NIH’s Eric Dishman: EHR access is a ‘fundamental’ pillar of precision medicine research

National Institutes of Health sign
All of Us Director Eric Dishman said NIH plans to invest in helping participants get access to an "increasingly richer and deeper record."

Access to EHR data will be a critical part of the National Institute of Health’s precision medicine research efforts, but even the director of the agency’s large-scale research initiative is sympathetic to the skepticism of prospective participants.

Eric Dishman, director of the All of Us campaign that plans to collect information from 1 million people, said access to a “holistic, longitudinal health records is just a fundamental pillar of the program,” in a video addressing concerns participants might have about turning their medical information over to government researchers.

RELATED: 'All of Us' program director Eric Dishman seeks to expand precision medicine to all

Dishman said 4,000 people have already gone through the onerous consent process and more than 6,000 are still moving through that process. While 2% have declined to participate because they don’t want to turn over their EHR, Dishman said it’s difficult to quantify the number of people who are preemptively put off by the idea.

“If you’re nervous about it, it’s good,” Dishman said. “Because you should pay attention to something that has such precious and personal data and know what’s going to happen with it.”

RELATED: Editor’s Corner—Why the Biden-Faulkner exchange over EHR access touched a nerve

Part of the program will also include NIH funding devoted to helping individuals that don’t have complete EHR “get access to an increasingly richer and deeper record,” which can be de-identified and use by researchers to develop new targeted cures. 

“In some cases, it may take a year or more for us to figure out the strategy to do that, but it’s a fundamental commitment to the program, a value proposition of the program and necessity for changing the game of precision medicine research,” he said.

 

Suggested Articles

Several experts say most insurers aren't factoring COVID-19 into their 2021 premiums for the ACA exchanges due to massive uncertainty.

With large numbers of Americans skeptical of a COVID-19 vaccine, CVS views its pharmacists as playing a key role in assuaging fears, said its CEO.

The COVID-19 pandemic is driving enormous demand for virtual mental health care services. Here is how much utilization has increased during COVID-19.